Free Trial
→ The end may be near for these iconic stocks (From Chaikin Analytics) (Ad)tc pixel
NASDAQ:WORX

SCWorx Q2 2025 Earnings Results & Report

SCWorx logo
$1.94 -0.20 (-9.11%)
As of 01:59 PM Eastern
This is a fair market value price provided by Massive. Learn more.

SCWorx reported Q2 2025 earnings on August 14, 2025. The company reported EPS of -$79.20, while revenue was $0.68 million.

Research:ProfileEarnings HistoryForecast

Earnings Announcement Details

Quarter
Q2 2025
Report Date
Time
During Market Hours

SCWorx EPS Results

Actual EPS
-$79.20
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

SCWorx Revenue Results

Actual Revenue
$0.68 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

SCWorx Q2 2025 Earnings FAQ

SCWorx (NASDAQ:WORX) reported earnings of -$79.20 per share for Q2 2025. The report was announced on Thursday, August 14, 2025.

SCWorx reported revenue of $0.68 million for Q2 2025.

SCWorx Earnings Headlines

SCWorx Corp. Highlights Nasdaq Relisting, Improved Gross Profit and Expanding Healthcare Customer Base
October 7, 2026  |  quiverquant.comQ
SCWorx Announces Resumption of Nasdaq Trading and Highlights Improved Operating Performance and Growth Strategy
October 7, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/07/3376783/0/en/scworx-announces-resumption-of-nasdaq-trading-and-highlights-improved-operating-performance-and-growth-strategy.html
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.tc pixel
October 15 at 1:00 AM  |  Stansberry Research (Ad)
SCWorx Announces Nasdaq Trading to Resume October 7, 2026
October 6, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/06/3375926/0/en/scworx-announces-nasdaq-trading-to-resume-october-7-2026.html
SCWorx Regains Nasdaq Compliance After Delisting Reconsideration
October 5, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/scworx-regains-nasdaq-compliance-after-delisting-reconsideration?utm_source=marketbeat.com&utm_medium=referral
SCWorx Corp. Regains Nasdaq Listing Compliance as Panel Approves Continued Listing and Trading Reinstatement
October 5, 2026  |  quiverquant.comQ
See More SCWorx Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like SCWorx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on SCWorx and other key companies, straight to your email.

About SCWorx

SCWorx (NASDAQ:WORX) is a healthcare technology company that provides software and services designed to help healthcare organizations manage supply chains and related operational data. Its platform is intended to support the organization of medical product information, supplier relationships, purchasing processes and inventory management.

The company’s solutions have been marketed to hospitals, healthcare systems and other healthcare providers seeking greater visibility into medical supplies and procurement activities. SCWorx has also provided data-management and analytics capabilities intended to help customers improve product catalog accuracy, identify sourcing opportunities and coordinate supply-chain operations.

SCWorx was founded in 2012 and is headquartered in New York. The company has been led by Marc Schessel, who has served as its chief executive officer and chairman. Publicly available information about its current operations and geographic reach is limited, so the company’s activities and leadership may change over time.

View SCWorx Profile
Earnings Tools